Drug Type Fusion protein |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | Attralus, Inc.Startup | 23 May 2024 |
Cardiovascular Diseases | Discovery | - | 23 May 2024 | |
Nervous System Diseases | Discovery | - | 23 May 2024 | |
Nervous System Diseases | Discovery | - | Attralus, Inc.Startup | 23 May 2024 |
Nutritional and Metabolic Diseases | Discovery | - | 23 May 2024 | |
Nutritional and Metabolic Diseases | Discovery | - | Attralus, Inc.Startup | 23 May 2024 |
Rare Diseases | Discovery | - | 23 May 2024 | |
Rare Diseases | Discovery | - | Attralus, Inc.Startup | 23 May 2024 |
Skin Diseases | Discovery | - | 23 May 2024 | |
Skin Diseases | Discovery | - | Attralus, Inc.Startup | 23 May 2024 |